Key result
Cardiac fibrosis is discussed as a primary therapeutic target, though specific clinical outcomes are not provided in the available abstract.
Key points are not available for this paper at this time.
[Figure: see text]
No takes yet. Share an insight, caveat, or question.
Major et al. (2019) studied this question. Cardiac fibrosis is discussed as a primary therapeutic target, though specific clinical outcomes are not provided in the available abstract.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: